quantisnow
FeedTopReportsPricing
⌘K
Live feed
11:19:22·328d
INSIDERFiling
Checkpoint Therapeutics Inc. logo

Director Rosenwald Lindsay A Md was granted 62,195 shares, closing all direct ownership in the company (SEC Form 4)

CKPT· Checkpoint Therapeutics Inc.
Health Care
Original source

Companies

  • CKPT
    Checkpoint Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Jan 13UpdateD. Boral Capital$9.00
  • Jul 14UpdateB. Riley Securities$7.00
  • Jan 25UpdateHC Wainwright & Co.$26.00

Related

  • SEC319d
    SEC Form 15-12G filed by Checkpoint Therapeutics Inc.
  • SEC323d
    SEC Form EFFECT filed by Checkpoint Therapeutics Inc.
  • SEC323d
    SEC Form EFFECT filed by Checkpoint Therapeutics Inc.
  • SEC323d
    SEC Form EFFECT filed by Checkpoint Therapeutics Inc.
  • SEC323d
    SEC Form EFFECT filed by Checkpoint Therapeutics Inc.
  • SEC323d
    SEC Form EFFECT filed by Checkpoint Therapeutics Inc.
  • SEC323d
    SEC Form EFFECT filed by Checkpoint Therapeutics Inc.
  • SEC324d
    Amendment: SEC Form SCHEDULE 13D/A filed by Checkpoint Therapeutics Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022